lamotrigine has been researched along with Epileptiform Neuralgia in 20 studies
Excerpt | Relevance | Reference |
---|---|---|
" In this study, we evaluated the efficacy and occurrence of side effects of lamotrigine (LTG) in comparison with carbamazepine (CBZ), in trigeminal neuralgia (TN) patients." | 9.15 | Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine. ( Abd Rahman, RB; Shaikh, S; Yaacob, HB, 2011) |
" We report 11 MS patients with trigeminal neuralgia (TN): 6 intolerant to a therapeutic dosage of CBZ, showing serious adverse effects and subsequently treated with a combination of low-dose CBZ and gabapentin (GBP) (group 1); 5 treated with lamotrigine (LMT), showing adverse effects and subsequently treated with GBP (group 2)." | 7.70 | Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. ( Leandri, M; Mancardi, GL; Messmer Uccelli, M; Solaro, C; Uccelli, A, 2000) |
"This paper reports on the effectiveness of oral lamotrigine in 15 patients suffering from "essential" trigeminal neuralgia and in five patients suffering symptomatic trigeminal neuralgia concomitant with multiple sclerosis." | 7.69 | Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. ( Albano, C; Cultrera, S; Favale, E; Fracassi, M; Leandri, M; Lunardi, G; Rubino, V, 1997) |
"Lamotrigine is a chemically novel antiepileptic drug which has not been adequately assessed for its antineuralgic properties." | 6.68 | Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. ( Chaudhry, Z; Mullens, LE; Nurmikko, TJ; Patton, DW; Zakrzewska, JM, 1997) |
" In this study, we evaluated the efficacy and occurrence of side effects of lamotrigine (LTG) in comparison with carbamazepine (CBZ), in trigeminal neuralgia (TN) patients." | 5.15 | Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine. ( Abd Rahman, RB; Shaikh, S; Yaacob, HB, 2011) |
" Memory alteration was least common with lamotrigine and oxcarbazepine, and there was less association between fatigues with oxcarbazepine/pregabalin." | 3.88 | Adverse effects of anti-epileptics in trigeminal neuralgiform pain. ( Cregg, R; Lee, G; O'Keeffe, AG; Reading, J; Tentolouris-Piperas, V; Zakrzewska, JM, 2018) |
" We report 11 MS patients with trigeminal neuralgia (TN): 6 intolerant to a therapeutic dosage of CBZ, showing serious adverse effects and subsequently treated with a combination of low-dose CBZ and gabapentin (GBP) (group 1); 5 treated with lamotrigine (LMT), showing adverse effects and subsequently treated with GBP (group 2)." | 3.70 | Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. ( Leandri, M; Mancardi, GL; Messmer Uccelli, M; Solaro, C; Uccelli, A, 2000) |
"This paper reports on the effectiveness of oral lamotrigine in 15 patients suffering from "essential" trigeminal neuralgia and in five patients suffering symptomatic trigeminal neuralgia concomitant with multiple sclerosis." | 3.69 | Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. ( Albano, C; Cultrera, S; Favale, E; Fracassi, M; Leandri, M; Lunardi, G; Rubino, V, 1997) |
"Lamotrigine is a chemically novel antiepileptic drug which has not been adequately assessed for its antineuralgic properties." | 2.68 | Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. ( Chaudhry, Z; Mullens, LE; Nurmikko, TJ; Patton, DW; Zakrzewska, JM, 1997) |
" When sodium channel blockers cannot reach full dosage because of side effects, an add-on treatment with lamotrigine or baclofen should be considered." | 2.58 | Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia. ( Cruccu, G; Di Stefano, G; Truini, A, 2018) |
"Trigeminal neuralgia is a unique neuropathic pain disorder with a specific therapy." | 2.42 | Management issues of neuropathic trigeminal pain from a medical perspective. ( Watson, CP, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (30.00) | 18.2507 |
2000's | 6 (30.00) | 29.6817 |
2010's | 7 (35.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Pergolizzi, JV | 1 |
Gharibo, C | 1 |
Magnusson, P | 1 |
Breve, F | 1 |
LeQuang, JA | 1 |
Varrassi, G | 1 |
Tentolouris-Piperas, V | 1 |
Lee, G | 1 |
Reading, J | 1 |
O'Keeffe, AG | 1 |
Zakrzewska, JM | 3 |
Cregg, R | 1 |
Solaro, CM | 1 |
Ferriero, G | 1 |
Di Stefano, G | 1 |
Truini, A | 1 |
Cruccu, G | 1 |
Lambru, G | 1 |
Matharu, MS | 1 |
Scrivani, S | 1 |
Wallin, D | 1 |
Moulton, EA | 1 |
Cole, S | 1 |
Wasan, AD | 1 |
Lockerman, L | 1 |
Bajwa, Z | 1 |
Upadhyay, J | 1 |
Becerra, L | 1 |
Borsook, D | 1 |
Martin, WJ | 1 |
Forouzanfar, T | 1 |
Shaikh, S | 1 |
Yaacob, HB | 1 |
Abd Rahman, RB | 1 |
Watson, CP | 1 |
Jorns, TP | 1 |
Canavero, S | 3 |
Bonicalzi, V | 3 |
Ferroli, P | 1 |
Zeme, S | 1 |
Montalenti, E | 1 |
Benna, P | 1 |
Lunardi, G | 1 |
Leandri, M | 3 |
Albano, C | 1 |
Cultrera, S | 1 |
Fracassi, M | 1 |
Rubino, V | 1 |
Favale, E | 1 |
Chaudhry, Z | 1 |
Nurmikko, TJ | 1 |
Patton, DW | 1 |
Mullens, LE | 1 |
Carrazana, EJ | 1 |
Schachter, SC | 1 |
Solaro, C | 2 |
Messmer Uccelli, M | 1 |
Uccelli, A | 1 |
Mancardi, GL | 2 |
Lundardi, G | 1 |
Inglese, M | 1 |
Messmer-Uccelli, M | 1 |
Gottlieb, A | 1 |
McCleane, GJ | 1 |
Christensen, D | 1 |
Gautron, M | 1 |
Guilbaud, G | 1 |
Kayser, V | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI[NCT00243152] | 6 participants (Actual) | Interventional | 2005-10-31 | Completed | |||
Lamotrigine in Trigeminal Neuralgia: Efficacy and Safety in Comparison With Carbamazepine[NCT00913107] | Phase 2/Phase 3 | 21 participants (Actual) | Interventional | 2007-09-30 | Completed | ||
Examining the Efficacy of Low Intensity Low Frequency Surface Acoustic Wave Ultrasound(LILF/SAWU) in Trigeminal Neuralgia Pain[NCT01447108] | Phase 4 | 16 participants (Actual) | Interventional | 2011-11-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
fMRI scans acquired Stimuli Type: Brush Stimulation Regions: Face (V2) Right and Left Sides Rating: Pain/ unpleasantness fMRI scans acquired Stimuli Type: Cold, threshold -1°C Stimulation Regions: Face (V2) Right and Left Sides Rating: Pain/ unpleasantness **Extra time allotted for probe repositioning** fMRI scans acquired Stimuli Type: Heat, threshold +1°C Stimulation Regions: Face (V2) Right and Left Sides Rating: Pain/ unpleasantness **Extra time allotted for probe repositioning** Cortical, subcortical, and brain stem sensory regions Z-scores Increase or decrease in activation as affected by the drug (NCT00243152)
Timeframe: Week 10 during scanning session
Intervention | Z-statistic (Number) | ||||||
---|---|---|---|---|---|---|---|
Heat Affected Thalamus (10,-14,8) | Heat Affected Post-Central (-56,-12,28) | Cold Affected Post-Central (68, -8, 32) | Cold Affected Thalamus (-4, -8, 0) | Brush Affected Post-Central (66,-16,14) | Brush Affected Thalamus (-14,-22, 4) | Brush Affected Spinal Trigeminal Nucles(2,-48,-68) | |
Lamotrigine vs Placebo | -2.9294 | -2.7323 | -2.5114 | -3.033 | 3.905 | -3.791 | 2.9058 |
"Quantitative Sensory Testing (QST)~Stimuli Type: Heat, Cold, Brush Stimulation Regions: Face Affected and contralateral Unaffected mirror area Rating: Pain/ unpleasantness Stimuli Type: Cold, threshold -1°C Stimulation Regions: Face Affected and contralateral Unaffected mirror area Rating: Pain/ unpleasantness Stimuli Type: Heat, threshold +1°C Stimulation Regions: Face Affected and contralateral Unaffected mirror area Rating: Pain/ unpleasantness~Ratings on a likert scale of 0-10 with 0 being defined as no pain and 10 being defined as worst possible pain" (NCT00243152)
Timeframe: week 10 (during the scan)
Intervention | scores on a pain scale (Mean) | |||||
---|---|---|---|---|---|---|
Heat Affected | Heat Unaffected | Cold Affected | Cold Unaffected | Brush Affected | Brush Unaffected | |
Lamotrigine | 3.2 | 3 | 2.1 | 2.2 | 2.8 | 1.2 |
Placebo | 5.5 | 4 | 2.5 | 1.1 | 3.9 | .4 |
6 reviews available for lamotrigine and Epileptiform Neuralgia
Article | Year |
---|---|
Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia.
Topics: Anticonvulsants; Antidepressive Agents; Baclofen; Carbamazepine; Drug Therapy, Combination; Gabapent | 2018 |
SUNCT, SUNA and trigeminal neuralgia: different disorders or variants of the same disorder?
Topics: Anticonvulsants; Carbamazepine; Deep Brain Stimulation; Functional Neuroimaging; Humans; Hypothalamu | 2014 |
The efficacy of anticonvulsants on orofacial pain: a systematic review.
Topics: Amines; Anticonvulsants; Burning Mouth Syndrome; Carbamazepine; Clonazepam; Cyclohexanecarboxylic Ac | 2011 |
Management issues of neuropathic trigeminal pain from a medical perspective.
Topics: Amines; Analgesics, Non-Narcotic; Anticonvulsants; Antidepressive Agents; Baclofen; Carbamazepine; C | 2004 |
Evidence-based approach to the medical management of trigeminal neuralgia.
Topics: Analgesics; Baclofen; Carbamazepine; Drug Therapy, Combination; Evidence-Based Medicine; Female; GAB | 2007 |
Lamotrigine in the management of neuropathic pain: a review of the literature.
Topics: Analgesics; Diabetic Neuropathies; Humans; Lamotrigine; Triazines; Trigeminal Neuralgia | 2000 |
5 trials available for lamotrigine and Epileptiform Neuralgia
Article | Year |
---|---|
A fMRI evaluation of lamotrigine for the treatment of trigeminal neuropathic pain: pilot study.
Topics: Adult; Amines; Anticonvulsants; Brain; Cold Temperature; Cross-Over Studies; Cyclohexanecarboxylic A | 2010 |
Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Carbamazepine; Cross-Over Studies; Female; Humans; Lamot | 2011 |
Lamotrigine control of trigeminal neuralgia: an expanded study.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Female; Humans; Lamotrigine; Male; Middle Aged; Tri | 1997 |
Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial.
Topics: Adult; Aged; Analgesics; Cross-Over Studies; Double-Blind Method; Female; Humans; Lamotrigine; Male; | 1997 |
Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis.
Topics: Analgesics; Analgesics, Non-Narcotic; Carbamazepine; Female; Humans; Lamotrigine; Male; Middle Aged; | 2000 |
9 other studies available for lamotrigine and Epileptiform Neuralgia
Article | Year |
---|---|
Pharmacotherapeutic management of trigeminal neuropathic pain: an update.
Topics: Anticonvulsants; Carbamazepine; Humans; Lamotrigine; Neuralgia; Trigeminal Neuralgia | 2022 |
Adverse effects of anti-epileptics in trigeminal neuralgiform pain.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Fatigue; Female; Humans; Lamot | 2018 |
Refactory Trigeminal Neuralgia successfully treated by combination therapy (Pregabalin plus Lamotrigine).
Topics: Aged; Anticonvulsants; Drug Therapy, Combination; Female; Humans; Lamotrigine; Male; Middle Aged; Pr | 2018 |
Lamotrigine control of idiopathic trigeminal neuralgia.
Topics: Adult; Aged; Analgesics, Non-Narcotic; Carbamazepine; Female; Follow-Up Studies; Humans; Lamotrigine | 1995 |
Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia.
Topics: Aged; Calcium Channel Blockers; Female; Follow-Up Studies; Humans; Lamotrigine; Male; Middle Aged; P | 1997 |
Alternative uses of lamotrigine and gabapentin in the treatment of trigeminal neuralgia.
Topics: Acetates; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Huma | 1998 |
Comments on Zakrzewska et al., PAIN, 73 (1997) 223-230.
Topics: Analgesics; Humans; Lamotrigine; Triazines; Trigeminal Neuralgia | 1998 |
Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis.
Topics: Acetates; Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dose-Res | 2000 |
Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic pain.
Topics: Acetates; Amines; Analgesics; Animals; Behavior, Animal; Cyclohexanecarboxylic Acids; Disease Models | 2001 |